Skip to main content

Table 3 Micronutrient level versus treatment outcomes

From: Micronutrient levels and their effects on the prognosis of visceral leishmaniasis treatment, a prospective cohort study

Micronutrient Treatment outcome RRa [95% CI]
Successful Not successful
Frequency % Frequency %
Zinc (mcg/dl) ≤58 211 16.1 135 10.3 0.66 [0.6–0.72]
59–98 387 29.6 36 2.8 0.98 [0.95–1.02]
> 99 511 39 29 2.2 Reference group
Iodine (mcg/l) ≤113 224 17.1 109 8.3 0.69 [0.64–0.75]
114–147 247 18.9 72 5.5 0.79 [0.75–0.84]
≥148 638 48.7 19 1.5 Reference group
Iron (mcg/dl) ≤46 321 24.5 200 15.3 0.61 [0.75–0.85]
47–48 146 11.2 0 0 0.99 [0.97–1]
≥49 642 49 0 0 Reference group
Selenium (ng/ml) ≤84 264 20.2 68 5.2 0.88 [0.83–0.93]
85–105 245 18.7 71 5.4 0.85 [0.8–0.91]
≥106 600 45.8 61 4.7 Reference group
Vitamin A (mcg/dl) ≤16 233 17.8 136 10.4 0.64 [0.59–0.69]
17–31 209 16 56 4.3 0.8 [0.75–0.85]
≥32 667 51 8 0.6 Reference group
Vitamin D (ng/ml) ≤15 281 21.5 112 8.6 0.63 [0.59–0.69]
16–27 219 16.7 27 2.1 0.79 [0.75–0.85]
≥28 609 46.5 61 4.7 Reference group
  1. aRR risk ratio